Market Movers: Gold Hits $4,000, Amazon Expands Pharmacy Kiosks, and Tech Giants Face Antitrust Scrutiny

Key Takeaways

  • Gold (XAU) has surged past $4,000 an ounce for the first time, marking a significant milestone in a three-year bull run driven by geopolitical uncertainty and investor demand for safe-haven assets.
  • Amazon Pharmacy (AMZN) is set to launch electronic prescription kiosks at its One Medical locations in Los Angeles starting December 2025, aiming to streamline medication access and combat unfilled prescriptions.
  • The German cartel office has initiated an investigation into Chinese e-commerce giant Temu (PDD) over concerns of merchant price influencing, raising questions about fair competition in the European marketplace.
  • Google (GOOG, GOOGL) is seeking to retain the right to bundle its popular mapping and video applications with its Gemini AI service, a move challenged by the Justice Department in ongoing antitrust proceedings.
  • The U.S. is expected to participate in a Paris meeting on Gaza's post-war transition, coinciding with ongoing indirect talks between Israel and Hamas on a U.S.-backed peace plan.

Gold's Historic Ascent Breaks $4,000 Mark Amid Global Instability

Gold prices have achieved an unprecedented milestone, breaking above $4,000 per ounce for the first time on record. This surge extends a remarkable three-year bull run, with the precious metal gaining approximately 50% in 2025 alone, following rises of 27% in 2024 and 13% in 2023. The ascent is largely attributed to heightened global political and economic uncertainty, including a U.S. government shutdown, trade wars, and ongoing conflicts in the Middle East and Ukraine, driving investors towards safe-haven assets.

Analysts at Goldman Sachs have reportedly raised their gold price forecast, with some suggesting the metal could reach $4,900 an ounce by the end of 2026. The strong demand is also fueled by central bank buying, a weaker U.S. dollar, and significant inflows into gold ETFs, indicating sustained investor appetite.

Amazon Pharmacy Expands Reach with In-Office Kiosks

Amazon Pharmacy (AMZN) is set to revolutionize prescription access by introducing electronic kiosks within its One Medical primary care offices. The initial rollout will begin in Los Angeles in December 2025, with plans for broader expansion. These kiosks aim to provide patients with immediate access to commonly prescribed medications, such as antibiotics and blood pressure drugs, directly after their appointments, eliminating the need for a separate pharmacy trip.

The initiative seeks to address the significant issue of unfilled prescriptions, which affects over a quarter of U.S. prescriptions annually. Patients can order through the Amazon app, receive a QR code, and pick up their medications within minutes. Licensed pharmacists will be available for virtual consultations, and the system is designed to be HIPAA-compliant, ensuring patient privacy. This move further integrates Amazon's healthcare offerings, following its $3.9 billion acquisition of One Medical in 2023.

Temu Under German Antitrust Investigation for Price Influencing

Chinese e-commerce platform Temu (PDD), operated by Dublin-based Whaleco Technology Limited, is facing an antitrust investigation by the German Federal Cartel Office. The probe focuses on suspicions that Temu may be imposing "inadmissible requirements" on how third-party merchants set prices on its German marketplace.

The German regulator, led by President Andreas Mundt, expressed concerns that such practices could restrict competition and potentially lead to higher prices across other sales channels. Temu, which boasts 19.3 million active users in Germany and over 100 million monthly active users across Europe, has stated its compliance with local laws and expressed confidence in resolving any concerns. This investigation follows a separate EU inquiry into Temu regarding the risk of illegal products on its platform and other potential breaches of digital legislation.

Google Fights to Bundle Gemini AI with Core Apps Amid Antitrust Scrutiny

Alphabet Inc.'s Google (GOOG, GOOGL) is pushing to maintain its right to bundle popular services like Google Maps and YouTube with its Gemini AI service, a stance articulated by its lawyers to a federal judge. This move comes as the Justice Department proposes measures that would prohibit such bundling, intensifying the ongoing antitrust battle against the tech giant.

Prosecutors argue that Google's bundling practices, including previous deals to pre-install its search engine on devices, reinforce its market dominance and hinder competition in the burgeoning AI sector. Internal documents reportedly showed Google considered exclusive deals for Gemini AI, Chrome, and its search app with Android phone makers like Samsung. The outcome of this legal challenge could significantly reshape how Google integrates its AI offerings and potentially impact competition across the tech industry.

U.S. to Attend Paris Meeting on Gaza Transition as Peace Talks Advance

The United States is expected to send an official to a ministerial meeting in Paris on Thursday to discuss the post-war transition in Gaza. This high-level diplomatic gathering will run in parallel with indirect talks between Israel and Hamas taking place in Sharm el-Sheikh, Egypt, focusing on U.S. President Donald Trump's peace plan for the region.

While U.S. Secretary of State Marco Rubio was initially expected to attend, diplomatic sources indicated that a U.S. official would still be present. The Paris meeting aims to delve into the implementation of the U.S. plan, assess collective international commitments, and discuss critical aspects like humanitarian aid, Gaza's reconstruction, and the disarmament of Hamas. President Trump has expressed optimism about the progress of the Gaza talks, with both Israel and Hamas reportedly responding positively to his proposed roadmap for ending the conflict.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top